Alvotech (ALVO) Change in Receivables (2021 - 2026)
Alvotech's (ALVO) quarterly Change in Receivables came in at $21.9 million in Q1 2026, up 142.8% YoY from $9.0 million in Q1 2025, and up 410.79% on a QoQ basis from -$7.1 million in Q4 2025.
Alvotech (ALVO) Change in Receivables (2021 - 2026) Analysis & Trends
Alvotech (ALVO) has 6 years of Change in Receivables data on file, last reported at $21.9 million in Q1 2026.
- Quarterly Change in Receivables rose 142.8% year-over-year to $21.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $106.1 million (up 172.55% YoY) and the FY2025 annual result came in at $93.2 million, up 178.26% from the prior year.
- Change in Receivables climbed to $21.9 million in Q1 2026, from -$7.1 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $48.8 million in Q3 2025 to a low of -$119.1 million in Q4 2024.
- A 5-year average of -$748533.3 and a median of $3.0 million in 2023 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2024 — Change in Receivables tumbled 1331.05% — and 2025, when it soared 22470.0%.
- Tracing ALVO's Change in Receivables over 5 years: stood at -$3.6 million in 2022, then tumbled by 132.66% to -$8.3 million in 2023, then plunged by 1331.05% to -$119.1 million in 2024, then soared by 94.08% to -$7.1 million in 2025, then jumped by 410.79% to $21.9 million in 2026.
- The last three Change in Receivables figures came in at $21.9 million (Q1 2026), -$7.1 million (Q4 2025), and $48.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alvotech | 1.30 Bn | 1.30 Bn | 5.09 Mn | 21.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.92 Mn |
| Mar 31, 2026 | 21.92 Mn |
| Dec 31, 2025 | -7.05 Mn |
| Dec 31, 2025 | -7.05 Mn |
| Sep 30, 2025 | 48.82 Mn |
| Sep 30, 2025 | 48.82 Mn |
| Jun 30, 2025 | 42.38 Mn |
| Jun 30, 2025 | 42.38 Mn |
| Mar 31, 2025 | 9.03 Mn |
| Mar 31, 2025 | 9.03 Mn |
| Dec 31, 2024 | -119.06 Mn |
| Dec 31, 2024 | -119.06 Mn |
| Sep 30, 2024 | 16.10 Mn |
| Sep 30, 2024 | 16.10 Mn |
| Jun 30, 2024 | -52.27 Mn |
| Jun 30, 2024 | -52.27 Mn |
| Mar 31, 2024 | 40,000.00 |
| Mar 31, 2024 | 40,000.00 |
| Dec 31, 2023 | -8.32 Mn |
| Dec 31, 2023 | -8.32 Mn |